Cholesterol levels in patients with multiple myeloma

Area of Science:

• Oncology
• Biochemistry
• Hematology

Background:

• Hypocholesterolemia is a known complication in various cancers.
• Multiple myeloma (MM) is a hematological malignancy affecting plasma cells.

Purpose of the Study:

• To investigate cholesterol levels in multiple myeloma patients.
• To determine the relationship between cholesterol levels and MM type and stage.

Main Methods:

• A study involving 102 MM patients and 71 healthy controls.
• Measurement of total cholesterol (TC), LDL-C, HDL-C, VLDL-C, and triglyceride levels.
• Comparison of lipid profiles between MM patients and controls, and across different MM stages.

Main Results:

• MM patients showed significantly lower TC, LDL-C, and HDL-C than controls.
• No significant differences in VLDL-C or triglyceride levels were observed.
• TC and LDL-C levels were higher in stage I MM patients compared to stages II and III.
• HDL-C levels were lower in stage III MM patients compared to controls.

Conclusions:

• Hypocholesterolemia is prevalent in multiple myeloma patients.
• Lower cholesterol levels may be attributed to increased clearance and utilization by myeloma cells.
• Cholesterol levels correlate with disease stage in MM.